MYD88 and lymphoproliferative syndrome: Although type II cryoglobulinemia can also be caused by lymphoproliferative disorders, only two reported cases have suggested that BTK inhibitors were effective in type II cryoglobulinemia, both of which involved patients with a mutation in the MyD88 gene (13, 14).